153 related articles for article (PubMed ID: 28166929)
1. Kinetics of plasma procalcitonin, soluble CD14, CCL2 and IL-10 after a sublethal infusion of lipopolysaccharide in horses.
Bonelli F; Meucci V; Divers TJ; Wagner B; Intorre L; Sgorbini M
Vet Immunol Immunopathol; 2017 Feb; 184():29-35. PubMed ID: 28166929
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lipopolysaccharides and soluble CD14 measurement between clinically endotoxaemic and nonendotoxaemic horses.
Fogle J; Jacob M; Blikslager A; Edwards A; Wagner B; Dean K; Fogle C
Equine Vet J; 2017 Mar; 49(2):155-159. PubMed ID: 27060869
[TBL] [Abstract][Full Text] [Related]
3. Analysis of soluble CD14 and its use as a biomarker in neonatal foals with septicemia and horses with recurrent airway obstruction.
Wagner B; Ainsworth DM; Freer H
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):124-8. PubMed ID: 23810420
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the role of soluble CD14 in hospitalized, sick horses.
Silva A; Wagner B; McKenzie HC; Desrochers AM; Furr MO
Vet Immunol Immunopathol; 2013 Oct; 155(4):264-9. PubMed ID: 24011901
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Uterine Lavage on Soluble CD14, Chemokine Ligand 2, and Interleukin 10 Levels in Mares With Postpartum Metritis.
Tukia E; Wagner B; Vainio K; Mönki J; Kareskoski M
J Equine Vet Sci; 2021 Mar; 98():103365. PubMed ID: 33663723
[TBL] [Abstract][Full Text] [Related]
6. Disparate effects of LPS infusion and carbohydrate overload on inflammatory gene expression in equine laminae.
Kwon S; Moore JN; Robertson TP; Hurley DJ; Wagner B; Vandenplas ML
Vet Immunol Immunopathol; 2013 Sep; 155(1-2):1-8. PubMed ID: 23820116
[TBL] [Abstract][Full Text] [Related]
7. Effects of the insulin sensitizing drug, pioglitazone, and lipopolysaccharide administration on markers of systemic inflammation and clinical parameters in horses.
Wearn JG; Suagee JK; Crisman MV; Corl BA; Hulver MW; Hodgson DR; Geor RJ; McCutcheon LJ
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):42-9. PubMed ID: 22088672
[TBL] [Abstract][Full Text] [Related]
8. Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome.
Bonelli F; Meucci V; Divers TJ; Jose-Cunilleras E; Corazza M; Tognetti R; Guidi G; Intorre L; Sgorbini M
J Vet Intern Med; 2015; 29(6):1689-91. PubMed ID: 26474412
[TBL] [Abstract][Full Text] [Related]
9. Effects of equine metabolic syndrome on inflammatory responses of horses to intravenous lipopolysaccharide infusion.
Tadros EM; Frank N; Donnell RL
Am J Vet Res; 2013 Jul; 74(7):1010-9. PubMed ID: 23802673
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-6 (IL-6) and IL-10 concentrations in normal and septic neonatal foals.
Burton AB; Wagner B; Erb HN; Ainsworth DM
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):122-8. PubMed ID: 19501415
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to P. gingivalis Lipopolysaccharide.
Andrukhov O; Andrukhova O; Özdemir B; Haririan H; Müller-Kern M; Moritz A; Rausch-Fan X
PLoS One; 2016; 11(8):e0160848. PubMed ID: 27504628
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin as a biomarker in equine chronic pneumopathies.
Barton AK; Pelli A; Rieger M; Gehlen H
BMC Vet Res; 2016 Dec; 12(1):281. PubMed ID: 27938364
[TBL] [Abstract][Full Text] [Related]
13. Effects of a "two-hit" model of organ damage on the systemic inflammatory response and development of laminitis in horses.
Tadros EM; Frank N; Newkirk KM; Donnell RL; Horohov DW
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):90-100. PubMed ID: 23026157
[TBL] [Abstract][Full Text] [Related]
14. A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses.
Rieger M; Kochleus C; Teschner D; Rascher D; Barton AK; Geerlof A; Kremmer E; Schmid M; Hartmann A; Gehlen H
Anal Bioanal Chem; 2014 Sep; 406(22):5507-12. PubMed ID: 24928115
[TBL] [Abstract][Full Text] [Related]
15. A comparison of equine and bovine sera as sources of lipopolysaccharide-binding protein activity in equine monocytes incubated with lipopolysaccharide.
Figueiredo MD; Salter CE; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):275-80. PubMed ID: 18023485
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide infusion up-regulates hepcidin mRNA expression in equine liver.
Oliveira-Filho JP; Badial PR; Cunha PH; Peiró JR; Araújo JP; Divers TJ; Winand NJ; Borges AS
Innate Immun; 2012 Jun; 18(3):438-46. PubMed ID: 21926164
[TBL] [Abstract][Full Text] [Related]
17. Effects of continuous or intermittent lipopolysaccharide administration for 48 hours on the systemic inflammatory response in horses.
Tadros EM; Frank N
Am J Vet Res; 2012 Sep; 73(9):1394-402. PubMed ID: 22924721
[TBL] [Abstract][Full Text] [Related]
18. Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14.
Laugerette F; Alligier M; Bastard JP; Drai J; Chanséaume E; Lambert-Porcheron S; Laville M; Morio B; Vidal H; Michalski MC
Mol Nutr Food Res; 2014 Jul; 58(7):1513-8. PubMed ID: 24687809
[TBL] [Abstract][Full Text] [Related]
19. Induction of early-phase endotoxin tolerance in horses.
Allen GK; Campbell-Beggs C; Robinson JA; Johnson PJ; Green EM
Equine Vet J; 1996 Jul; 28(4):269-74. PubMed ID: 8818592
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid lipopolysaccharide-binding protein and soluble CD14 as mediators of the inflammatory response in preterm labor.
Gardella C; Hitti J; Martin TR; Ruzinski JT; Eschenbach D
Am J Obstet Gynecol; 2001 May; 184(6):1241-8. PubMed ID: 11349195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
